Healthcare resource utilization associated with ivacaftor use in patients with cystic fibrosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Healthcare resource utilization associated with ivacaftor use in patients with cystic fibrosis
Authors
Keywords
-
Journal
JOURNAL OF MEDICAL ECONOMICS
Volume 19, Issue 9, Pages 845-851
Publisher
Informa UK Limited
Online
2016-04-14
DOI
10.1080/13696998.2016.1178125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tackling the increasing complexity of CF care
- (2015) Gregory S. Sawicki et al. PEDIATRIC PULMONOLOGY
- Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
- (2014) Steven M. Rowe et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis
- (2014) Penny Whiting et al. HEALTH TECHNOLOGY ASSESSMENT
- Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with aG551DMutation
- (2013) Jane C. Davies et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cystic Fibrosis Pulmonary Guidelines
- (2013) Peter J. Mogayzel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The impact of medication adherence on lung health outcomes in cystic fibrosis
- (2013) Michelle N. Eakin et al. CURRENT OPINION IN PULMONARY MEDICINE
- Pricing for Orphan Drugs
- (2013) Brian P. O’Sullivan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study
- (2012) Judy M. Bradley et al. EUROPEAN RESPIRATORY JOURNAL
- Managing treatment complexity in cystic fibrosis: Challenges and Opportunities
- (2012) Gregory S. Sawicki et al. PEDIATRIC PULMONOLOGY
- Resource Use, Costs, and Utility Estimates for Patients with Cystic Fibrosis with Mild Impairment in Lung Function: Analysis of Data Collected Alongside a 48-Week Multicenter Clinical Trial
- (2012) Esi Morgan DeWitt et al. VALUE IN HEALTH
- Longitudinal association between medication adherence and lung health in people with cystic fibrosis
- (2011) Michelle N. Eakin et al. Journal of Cystic Fibrosis
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis
- (2011) K. de Boer et al. THORAX
- Barriers to adherence in adolescents and young adults with cystic fibrosis: a questionnaire study in young patients and their parents
- (2011) Vibeke Bregnballe et al. Patient Preference and Adherence
- Adherence and persistence in patients with postmenopausal osteoporosis treated with raloxifene
- (2010) V. Ziller et al. CLIMACTERIC
- Adherence and persistence in patients with severe osteoporosis treated with teriparatide
- (2010) V. Ziller et al. CURRENT MEDICAL RESEARCH AND OPINION
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
- (2009) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evolution of costs of care for cystic fibrosis patients after clinical guidelines implementation in a French network
- (2008) Laure Huot et al. Journal of Cystic Fibrosis
- High treatment burden in adults with cystic fibrosis: Challenges to disease self-management
- (2008) Gregory S. Sawicki et al. Journal of Cystic Fibrosis
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started